Search results

This study aims to analyse how the adoption of Industry 4.0 technologies can help different types of agri-food supply chains introduce and manage innovations in response to the challenges and opportunities that emerged following the COVID-19 pandemic.

A systematic literature review methodology was used to bring together the most relevant contributions from different disciplines and provide comprehensive results on the use of I4.0 technologies in the agri-food industry.

Four technological clusters are identified, which group together the I4.0 technologies based on the applications in the agri-food industry, the objectives and the advantages provided. In addition, three types of agri-food supply chains have been identified and their configuration and dynamics have been studied. Finally, the I4.0 technologies most suited for each type of supply chain have been identified, and suggestions on how to effectively introduce and manage innovations at different levels of the supply chain are provided.

The study highlights how the effective adoption of I4.0 technologies in the agri-food industry depends on the characteristics of the supply chains. Technologies can be used for different purposes and managers should carefully consider the objectives to be achieved and the synergies between technologies and supply chain dynamics.

Health care systems aspire to adopt integration strategies shifting the focus from acute care to a broader focus on community-based health and social services. Real-world examples demonstrating effective delivery of integrated care are essential.

In this article, we introduce UHN Connected Care Hub, an innovative model of care comprising an interdisciplinary team designing sustainable, shareable practices across the continuum of care alongside community and health organization partnerships.

We describe UHN Connected Care Hub’s ability to identify patients from high-risk population and collaborate to delivery timely care, in detailing the real world experience of this model of care in the organization of a centralized system of micro-clinics to administer a therapeutic for pre-exposure prophylaxis against COVID-19 (Tixagevimab/cilgavimab [Evusheld]) in a population of immunocompromised patients.

Having a centralized system of micro-clinics for care delivery presents opportunities for increased adaptability, patient accessibility, enhanced community partnerships and integratedness. Expansion in the scope of services could also create new opportunities in preventative therapies for optimizing the cost effectiveness and quality of health care provided at the population level.

There is limited evidence on how to efficiently deliver integrated care, particularly to vulnerable and co-morbid patients. We discuss how dynamic organizations with proper infrastructure and a network of healthcare partnerships may allow a more fluid response to rapidly changing policies and procedures and facilitate preparedness for future health care crises or pandemics.